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• Radiosynthesis: Optimization 18F labelling
• Solvent 
• Temperature
• Mass of the precursor
• In vivo testing
• PC-3 xenograft (5 x 106 cells) (n=2). 
• Radiosynthesis 20 minutes in acetonitrile at 120°C. 
• Followed by deprotection with HCl (4M/dioxane) 5 minutes at 90°C.
• Purification was done by means of semi-prep HPLC.
• Final formulation: 20% EtOH/80% PBS mixture. 
• Dynamic µPET-scan acquired for 2 hours after injection of 18.5 MBq. 
• Volumes of interest are drawn around the tumor and the contralateral side as reference region with PMOD. 
MATERIALS & METHODS
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CONCLUSIONS
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Cancer is characterized by upregulation of nutrient transporters such as GLUT-1, LAT-1 and ASCT-2. [18F] FDG is the golden 
standard in oncology metabolism imaging, however this tracer shows sub-optimal characteristics in several tumors (e.g. 
brain-, prostate-, colorectal cancer). In a search to address these drawbacks, a 18F labeled inhibitor ([18F] (S)-2-amino-4-((2-
((3-fluorobenzyl)oxy)benzyl)(2-((3-(fluoromethyl)benzyl)oxy)benzyl)amino)butanoic acid) of ASCT-2 was developed. 
INTRODUCTION
With this study we report a new radiolabeled inhibitor of ASCT-2, which shows a good TBR. Further 
experiments are needed to explore the imaging potential of the ASCT-2 transporter. Optimal labelling 
conditions are also reported which suggest the labelling should occur in acetonitrile with a temperature of 
120°C. 
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Figure 1: Labelling yield in function of different 
solvents. Altering the solvent to acetonitrile
resulted in substantial increase in labelling yield.
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Figure 2: In the temperature-yield curve an inflection 
point is seen between 100°C and 120°C, suggesting 
this accounts for the Ekin necessary for good labelling 
yields. 
Figure 3: Labelling yield in function of the mass 
shows increase in yield at 2mg.  Increasing the 
amount of precursor further from 2mg to 8mg did 
not increase the labelling yield significantly. 
Figure 4: µPET/CT image of PC-3 xenograft.
The tracer shows in vivo uptake in the tumor and makes a clear delineation of the 
tumor possible. Furthermore it is predominantly cleared via biliary transport and in a 
minor amount to the bladder. 
The tracer reports an optimal uptake in the tumor after 20 minutes and an average 
tumor to background ratio of 1.85 ± 0,13 (n=2). 
